ArticleInternational journal of pharmaceutics: X2025

Enhance therapeutic efficacy of BiTE (HER2/CD3) for HER2- positive tumors through

Huifang Zong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.